Free Trial

QT Imaging (QTI) Competitors

QT Imaging logo
$1.71 -0.23 (-11.86%)
As of 07/14/2025

QTI vs. TLSI, INGN, SGHT, PROF, CVRX, KRMD, ELMD, PDEX, LNSR, and RCEL

Should you be buying QT Imaging stock or one of its competitors? The main competitors of QT Imaging include TriSalus Life Sciences (TLSI), Inogen (INGN), Sight Sciences (SGHT), Profound Medical (PROF), CVRx (CVRX), KORU Medical Systems (KRMD), Electromed (ELMD), Pro-Dex (PDEX), LENSAR (LNSR), and Avita Medical (RCEL). These companies are all part of the "medical equipment" industry.

QT Imaging vs. Its Competitors

QT Imaging (NASDAQ:QTI) and TriSalus Life Sciences (NASDAQ:TLSI) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, dividends, risk, institutional ownership, profitability, analyst recommendations, valuation and media sentiment.

In the previous week, QT Imaging and QT Imaging both had 1 articles in the media. TriSalus Life Sciences' average media sentiment score of 1.89 beat QT Imaging's score of 1.45 indicating that TriSalus Life Sciences is being referred to more favorably in the news media.

Company Overall Sentiment
QT Imaging Positive
TriSalus Life Sciences Very Positive

24.2% of QT Imaging shares are owned by institutional investors. Comparatively, 2.6% of TriSalus Life Sciences shares are owned by institutional investors. 75.4% of QT Imaging shares are owned by company insiders. Comparatively, 27.5% of TriSalus Life Sciences shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

QT Imaging has higher earnings, but lower revenue than TriSalus Life Sciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
QT Imaging$4.00M11.61-$4.03MN/AN/A
TriSalus Life Sciences$29.43M6.06-$30.05M-$1.12-4.21

QT Imaging has a beta of -0.2, indicating that its stock price is 120% less volatile than the S&P 500. Comparatively, TriSalus Life Sciences has a beta of 0.5, indicating that its stock price is 50% less volatile than the S&P 500.

TriSalus Life Sciences has a consensus target price of $10.75, indicating a potential upside of 128.24%. Given TriSalus Life Sciences' stronger consensus rating and higher probable upside, analysts plainly believe TriSalus Life Sciences is more favorable than QT Imaging.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
QT Imaging
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
TriSalus Life Sciences
0 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
2 Strong Buy rating(s)
3.25

QT Imaging has a net margin of 0.00% compared to TriSalus Life Sciences' net margin of -84.67%.

Company Net Margins Return on Equity Return on Assets
QT ImagingN/A N/A -65.94%
TriSalus Life Sciences -84.67%N/A -111.63%

Summary

TriSalus Life Sciences beats QT Imaging on 7 of the 13 factors compared between the two stocks.

Get QT Imaging News Delivered to You Automatically

Sign up to receive the latest news and ratings for QTI and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding QTI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

QTI vs. The Competition

MetricQT ImagingElectromedical equipment IndustryMedical SectorNASDAQ Exchange
Market Cap$46.40M$35.23M$5.52B$9.32B
Dividend YieldN/AN/A4.25%4.05%
P/E RatioN/A3.1228.1519.68
Price / Sales11.61233.71437.63100.28
Price / CashN/A41.3635.5357.53
Price / Book-0.901.998.235.67
Net Income-$4.03M-$2.66M$3.23B$257.51M
7 Day Performance-17.79%-6.25%-0.01%0.52%
1 Month Performance106.27%23.03%5.61%8.84%
1 Year Performance143.24%114.81%26.52%14.18%

QT Imaging Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
QTI
QT Imaging
N/A$1.71
-11.9%
N/A+134.2%$46.40M$4.00M0.00N/APositive News
TLSI
TriSalus Life Sciences
2.9853 of 5 stars
$5.17
+4.2%
$10.75
+107.9%
-9.0%$195.63M$32.14M-4.62106Positive News
INGN
Inogen
4.2277 of 5 stars
$7.26
flat
$11.00
+51.5%
-28.7%$195.20M$339.96M-6.311,030
SGHT
Sight Sciences
1.5714 of 5 stars
$3.55
+2.3%
$4.10
+15.5%
-57.3%$183.54M$79.87M-3.62210News Coverage
Analyst Forecast
PROF
Profound Medical
2.8884 of 5 stars
$5.99
-1.6%
$11.50
+92.0%
-37.7%$180M$10.68M-4.91150Gap Down
CVRX
CVRx
3.0523 of 5 stars
$6.75
+2.4%
$14.50
+114.8%
-26.6%$175.97M$51.29M-3.10160News Coverage
Positive News
KRMD
KORU Medical Systems
2.7211 of 5 stars
$3.80
+3.5%
$4.50
+18.4%
+17.6%$175.33M$33.65M-34.5580
ELMD
Electromed
0.8619 of 5 stars
$20.02
-0.5%
$38.00
+89.8%
+20.2%$167.89M$61.44M26.69160
PDEX
Pro-Dex
2.6336 of 5 stars
$47.69
+3.2%
$56.00
+17.4%
+144.1%$155.47M$53.84M17.03140News Coverage
Positive News
LNSR
LENSAR
1.2914 of 5 stars
$13.14
+2.3%
$15.00
+14.2%
+150.5%$154.92M$53.49M-2.71110Positive News
RCEL
Avita Medical
1.3506 of 5 stars
$5.61
+8.5%
$16.50
+194.1%
-45.7%$148.27M$64.25M-2.56130Positive News

Related Companies and Tools


This page (NASDAQ:QTI) was last updated on 7/16/2025 by MarketBeat.com Staff
From Our Partners